Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Short Communication

Detection of Antibodies against Toxoplasma from Human Serum Sample using ELISA

Author(s): Kirtika Sharma, Saumya Srivastava, Aditya Kundu and Vibhor Tak*

Volume 23, Issue 2, 2023

Published on: 03 October, 2022

Article ID: e130922208785 Pages: 3

DOI: 10.2174/1871526522666220913152447

Price: $65

Open Access Journals Promotions 2
Abstract

Background: Toxoplasmosis is a common worldwide zoonotic infection affecting warm blooded animals and humans caused by Toxoplasma gondii. Clinical features range from mildfebrile illness and lymphadenopathy in the immunocompetent host to encephalitisin the immunosuppressed host (E.g. HIV infected patients). Congenital infection can also occur. For effective control and treatment of toxoplasmosis, accurate detection of T. gondii infection is important.

Objective: In this study, ELISA detecting anti-toxoplasma antibodies IgM and IgG has been used for diagnosing Toxoplasmosis in patients.

Methods: Enzyme-linked immunosorbentassay (ELISA) was carried out in serum samples collected from 40 patients to detect anti-toxoplasma IgG and IgM antibodies as a part of work up in suspected cases. Relevant clinical history was also taken.

Results: Of the total 40 samples taken, only one sample came positive for IgM and 9 came positive for IgG antibody. All patients who were seropositivefor T. gondii antibodies had HIV infection. Five patients were in the age group between 30 to 40 years.

Conclusion: From the limited data available in this study, it may be recommended to screen for T. gondii antibodies in HIV patients.

Keywords: Toxoplasmosis, Toxoplasma gondii, ELISA, HIV, IgG, IgM.

Graphical Abstract
[1]
Bhattacharyya S, Khurana S, Dubey ML. Anti-Toxoplasma gondii antibody detection in serum and urine samples by enzyme-linked immunosorbent assay in HIV-infected patients. Indian J Pathol Microbiol 2013; 56(1): 20-3.
[http://dx.doi.org/10.4103/0377-4929.116143] [PMID: 23924553]
[2]
Parmley SF, Sgarlato GD, Mark J, Prince JB, Remington JS. Expression, characterization, and serologic reactivity of recombinant surface antigen P22 of Toxoplasma gondii. J Clin Microbiol 1992; 30(5): 1127-33.
[http://dx.doi.org/10.1128/jcm.30.5.1127-1133.1992] [PMID: 1583109]
[3]
Dubey JP. The history of Toxoplasma gondii-the first 100 years. J Eukaryot Microbiol 2008; 55(6): 467-75.
[http://dx.doi.org/10.1111/j.1550-7408.2008.00345.x] [PMID: 19120791]
[4]
Ybañez RHD, Ybañez AP, Nishikawa Y. Review on the current trends of toxoplasmosis serodiagnosis in humans. Front Cell Infect Microbiol 2020; 10: 204.
[http://dx.doi.org/10.3389/fcimb.2020.00204] [PMID: 32457848]
[5]
Vidal JE, Colombo FA, Penalva de Oliveira AC, Focaccia R, Pereira-Chioccola VL. PCR assay using cerebrospinal fluid for diagnosis of cerebral toxoplasmosis in Brazilian AIDS patients. J Clin Microbiol 2004; 42(10): 4765-8.
[http://dx.doi.org/10.1128/JCM.42.10.4765-4768.2004] [PMID: 15472338]
[6]
Zumla A, Savva D, Wheeler RB, et al. Toxoplasma serology in Zambian and Ugandan patients infected with the human immunodeficiency virus. Trans R Soc Trop Med Hyg 1991; 85(2): 227-9.
[http://dx.doi.org/10.1016/0035-9203(91)90034-V] [PMID: 1887478]
[7]
Mao F, Yang Y, Chen Y, et al. Seroprevalence and risk factors of Toxoplasma gondii infection among high-risk populations in Jiangsu Province, Eastern China. Front Cell Infect Microbiol 2021; 11: 783654.
[http://dx.doi.org/10.3389/fcimb.2021.783654] [PMID: 34778115]
[8]
Fang EE, Nyasa RB, Ndi EM, et al. Investigating the risk factors for seroprevalence and the correlation between CD4+ T-cell count and humoral antibody responses to Toxoplasma gondii infection amongst HIV patients in the Bamenda Health District, Cameroon. PLoS One 2021; 16(12): e0256947.
[http://dx.doi.org/10.1371/journal.pone.0256947] [PMID: 34855762]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy